News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
216 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Drug Development
First Gastric Cancer Patient Dosed in Clinical Trial Collaboration Evaluating Halozyme’s PEGPH20 in Combination With Anti-PDL1 Immunotherapy
Halozyme today announced the initiation of a multi-arm clinical trial evaluating PEGPH20, Halozyme’s investigational new drug, in combination with atezolizumab (TECENTRIQ), an anti-PDL1 cancer immunotherapy from Genentech, a member of the Roche Group.
October 25, 2017
·
5 min read
Zeus’ Sub-Lite-Wall StreamLiner Series Poised to Become New Design Standard for Improved Access in Catheter Delivery
Zeus has released its latest thin-walled PTFE catheter liner as part of their Sub-Lite-Wall StreamLiner series.
October 25, 2017
·
2 min read
Business
KNOW Bio Strengthens Leadership With the Addition of Four New Board Members
KNOW Bio today announced the addition of Haywood Cochrane, Phil Hodges, Harry Smith, and Anne Whitaker to its Board of Managers.
October 25, 2017
·
5 min read
FDA
Ortek Therapeutics Announces FDA Clearance For Breakthrough Electronic Cavity Detection Device
Ortek Therapeutics today announced that the Ortek ECD received FDA clearance from the FDA.
October 25, 2017
·
3 min read
Drug Development
Neovii Announces Publication in Journal of Clinical Oncology Demonstrating Grafalon Reduces Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplantation
The randomized, double blind, phase III, trial investigates the utility of Grafalon in reducing moderate to severe chronic graft-versus-host-disease.
October 25, 2017
·
5 min read
BioMidwest
Atrenne Integrated Solutions Expands into Medical Electronics Manufacturing
Atrenne Integrated Solutions announced today, its subsidiary, AbelConn Electronics, has been selected as the electronics manufacturer for a leading edge medical company.
October 25, 2017
·
1 min read
Business
Amgen Announces 2017 Fourth Quarter Dividend
Amgen today announced that its Board of Directors declared a $1.15 per share dividend for the fourth quarter of 2017.
October 25, 2017
·
5 min read
Business
Accuray Generated $55.6M in First Quarter Gross Orders; Revenue Increased 5 Percent Year over Year
Accuray today reported financial results for the first fiscal quarter ended September 30, 2017.
October 25, 2017
·
17 min read
Business
Abaxis Reports Financial Performance for the Second Quarter of Fiscal 2018 and Declares Quarterly Cash Dividend
Abaxis today reported financial results for the second fiscal quarter ended September 30, 2017.
October 25, 2017
·
24 min read
Biotech Beach
NuVasive Announces $100 Million Share Repurchase Program
NuVasive today announced that its Board of Directors approved a share repurchase program authorizing the purchase of up to $100M of the Company’s common stock over a three-year period commencing October 25, 2017.
October 25, 2017
·
3 min read
Previous
15 of 22
Next